Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: VD026R6TCI

Pharmacology

Action Mechanism of Action Reference
INHIBITOR RSPO3-LGR4 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3990031
FDA SRS VD026R6TCI